Pliant Therapeutics, Inc.

NasdaqGS:PLRX 株式レポート

時価総額:US$923.6m

Pliant Therapeutics マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Bernard Coulie

最高経営責任者

US$11.2m

報酬総額

CEO給与比率5.5%
CEO在任期間8.8yrs
CEOの所有権1.1%
経営陣の平均在職期間8.7yrs
取締役会の平均在任期間7.1yrs

経営陣の近況

Should Shareholders Reconsider Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) CEO Compensation Package?

Jun 07
Should Shareholders Reconsider Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) CEO Compensation Package?

Recent updates

Is Pliant Therapeutics (NASDAQ:PLRX) Using Too Much Debt?

Sep 13
Is Pliant Therapeutics (NASDAQ:PLRX) Using Too Much Debt?

Pliant Therapeutics: Good Data, But Will Need Watching

Sep 11

Should Shareholders Reconsider Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) CEO Compensation Package?

Jun 07
Should Shareholders Reconsider Pliant Therapeutics, Inc.'s (NASDAQ:PLRX) CEO Compensation Package?

Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?

Feb 27
Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?

Is Pliant Therapeutics (NASDAQ:PLRX) Using Debt Sensibly?

Jul 21
Is Pliant Therapeutics (NASDAQ:PLRX) Using Debt Sensibly?

Health Check: How Prudently Does Pliant Therapeutics (NASDAQ:PLRX) Use Debt?

Mar 13
Health Check: How Prudently Does Pliant Therapeutics (NASDAQ:PLRX) Use Debt?

Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?

Sep 10
Is Pliant Therapeutics (NASDAQ:PLRX) Weighed On By Its Debt Load?

Pliant Therapeutics: Wait For A Better Price To Get In

Aug 20

Pliant Therapeutics GAAP EPS of -$0.82 misses by $0.01, revenue of $4.99M

Aug 08

Is Pliant Therapeutics (NASDAQ:PLRX) In A Good Position To Deliver On Growth Plans?

Jul 28
Is Pliant Therapeutics (NASDAQ:PLRX) In A Good Position To Deliver On Growth Plans?

Pliant's PLN-74809 gets FDA fast track status for liver disease

Jul 21

Pliant climbs 48% as mid-stage trial for lung disease therapy meets key goals

Jul 11

Pliant: Major Catalyst Expected Beginning Of 2023

Jun 03

We're Keeping An Eye On Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Rate

Apr 22
We're Keeping An Eye On Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Rate

Here's Why We're Not Too Worried About Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation

Dec 29
Here's Why We're Not Too Worried About Pliant Therapeutics' (NASDAQ:PLRX) Cash Burn Situation

We Think Pliant Therapeutics (NASDAQ:PLRX) Can Afford To Drive Business Growth

Sep 07
We Think Pliant Therapeutics (NASDAQ:PLRX) Can Afford To Drive Business Growth

Analysts Have Just Cut Their Pliant Therapeutics, Inc. (NASDAQ:PLRX) Revenue Estimates By 12%

May 17
Analysts Have Just Cut Their Pliant Therapeutics, Inc. (NASDAQ:PLRX) Revenue Estimates By 12%

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

May 13
Pliant Therapeutics, Inc. (NASDAQ:PLRX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Pliant Therapeutics (NASDAQ:PLRX) Is In A Good Position To Deliver On Growth Plans

Mar 22
Pliant Therapeutics (NASDAQ:PLRX) Is In A Good Position To Deliver On Growth Plans

CEO報酬分析

Pliant Therapeutics の収益と比較して、Bernard Coulie の報酬はどのように変化したか?
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$185m

Mar 31 2024n/an/a

-US$171m

Dec 31 2023US$11mUS$610k

-US$161m

Sep 30 2023n/an/a

-US$155m

Jun 30 2023n/an/a

-US$144m

Mar 31 2023n/an/a

-US$133m

Dec 31 2022US$11mUS$587k

-US$123m

Sep 30 2022n/an/a

-US$113m

Jun 30 2022n/an/a

-US$109m

Mar 31 2022n/an/a

-US$103m

Dec 31 2021US$5mUS$556k

-US$97m

Sep 30 2021n/an/a

-US$92m

Jun 30 2021n/an/a

-US$81m

Mar 31 2021n/an/a

-US$75m

Dec 31 2020US$2mUS$499k

-US$42m

Sep 30 2020n/an/a

US$18m

Jun 30 2020n/an/a

US$19m

Mar 31 2020n/an/a

US$20m

Dec 31 2019US$2mUS$428k

-US$7m

報酬と市場: Bernardの 総報酬 ($USD 11.17M ) は、 US市場 ($USD 3.18M ) の同規模の企業の平均を上回っています。

報酬と収益: Bernardの報酬は増加しましたが、会社は利益を上げていません。


CEO(最高経営責任者

Bernard Coulie (58 yo)

8.8yrs

在職期間

US$11,165,999

報酬

Dr. Bernard Coulie, Ph D, M.D. M.B.A. is Independent Director of Septerna, Inc. from December 2023. He serves as Independent Director at SQZ Biotechnologies Company since July 2021 and serves as its Indepe...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Bernard Coulie
Presidentno dataUS$11.17m1.1%
$ 10.1m
Keith Cummings
Chief Financial Officer5.9yrsUS$4.44m0.31%
$ 2.9m
Mike Ouimette
General Counsel & Corporate Secretary4.1yrsUS$3.32m0.060%
$ 555.1k
Johannes Hull
Chief Business Officer8.7yrsUS$4.36m0.32%
$ 2.9m
Eric Lefebvre
Chief Medical Officer6.5yrsUS$4.69m0.22%
$ 2.0m
Rik Derynck
Scientific Founder & Member of Scientific Advisory Board9.8yrsデータなしデータなし
Dean Sheppard
Scientific Founder & Member of Scientific Advisory Board9.8yrsデータなしデータなし
Bill DeGrado
Scientific Founder & Member of Scientific Advisory Board9.8yrsデータなしデータなし
Hal Chapman
Scientific Founder & Member of Scientific Advisory Board9.8yrsデータなしデータなし
Craig Muir
Interim Chief Technology Officerno dataデータなしデータなし
Christopher Keenan
Vice President of Investor Relations & Corporate Communicationsno dataデータなしデータなし
Lily Cheung
Chief Human Resources Officer1.8yrsデータなし0.0013%
$ 12.1k

8.7yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: PLRXの経営陣は経験豊富で経験豊富です(平均在職期間は8.7年)。


取締役

名称ポジション在職期間報酬所有権
Bernard Coulie
President8.8yrsUS$11.17m1.1%
$ 10.1m
Rik Derynck
Scientific Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Dean Sheppard
Scientific Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Bill DeGrado
Scientific Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Hal Chapman
Scientific Founder & Member of Scientific Advisory Boardno dataデータなしデータなし
Gayle Crowell
Independent Director4.9yrsUS$278.71k0%
$ 0
Brian Metcalf
Member of Scientific Advisory Boardno dataデータなしデータなし
Suzanne Bruhn
Independent Director8.3yrsUS$277.21k0.058%
$ 532.9k
John Curnutte
Independent Director7.3yrsUS$271.96k0.048%
$ 444.7k
Hoyoung Huh
Independent Chairman6.9yrsUS$296.71k0.16%
$ 1.5m
Smital Shah
Independent Director5.7yrsUS$277.96k0%
$ 0
Bill Greenlee
Member of Scientific Advisory Boardno dataデータなしデータなし

7.1yrs

平均在職期間

61yo

平均年齢

経験豊富なボード: PLRXの 取締役会経験豊富 であると考えられます ( 7.1年の平均在任期間)。